Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Marpai Inc (MRAI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: MRAI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $6
1 Year Target Price $6
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -59.68% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 23.51M USD | Price to earnings Ratio - | 1Y Target Price 6 |
Price to earnings Ratio - | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta 4.58 | 52 Weeks Range 0.46 - 1.70 | Updated Date 10/17/2025 |
52 Weeks Range 0.46 - 1.70 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.92 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -51.35% | Operating Margin (TTM) -77.47% |
Management Effectiveness
Return on Assets (TTM) -40.88% | Return on Equity (TTM) -1359.59% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 28087848 | Price to Sales(TTM) 0.99 |
Enterprise Value 28087848 | Price to Sales(TTM) 0.99 | ||
Enterprise Value to Revenue 0.81 | Enterprise Value to EBITDA -0.89 | Shares Outstanding 17417092 | Shares Floating 8405671 |
Shares Outstanding 17417092 | Shares Floating 8405671 | ||
Percent Insiders 51.11 | Percent Institutions 10.8 |
Upturn AI SWOT
Marpai Inc
Company Overview
History and Background
Marpai, Inc. (MRAI) was founded in 2016. It is a technology company that uses artificial intelligence (AI) to improve healthcare outcomes and reduce costs for self-funded employers. It offers third-party administration (TPA) services and AI-powered preventative solutions.
Core Business Areas
- Third-Party Administration (TPA) Services: Provides claims processing, benefit administration, and member support for self-funded employers.
- AI-Powered Preventative Solutions: Utilizes AI to identify and manage high-risk individuals, promoting preventative care and reducing overall healthcare costs.
Leadership and Structure
Damien Lamendola serves as the CEO. The company has a board of directors and a management team overseeing various departments, including technology, operations, and sales.
Top Products and Market Share
Key Offerings
- Marpai Health Plan Services: Offers a health plan solution that utilizes AI to predict and prevent health issues. Market share data is not readily available for this specific offering. Competitors include traditional health insurance companies and other TPA providers like UnitedHealth Group (UNH) and Cigna (CI).
- Claims Processing Technology: AI-driven claims processing system that aims to improve accuracy and efficiency. Market share data is not publicly available. Competitors include large insurance companies and other claims processing platforms from companies like Optum (UNH).
Market Dynamics
Industry Overview
The healthcare benefits administration industry is experiencing growth due to rising healthcare costs and the increasing adoption of self-funded health plans by employers.
Positioning
Marpai aims to differentiate itself through its AI-driven approach, promising better cost control and improved health outcomes compared to traditional TPAs.
Total Addressable Market (TAM)
The TAM for healthcare benefits administration is substantial, estimated to be hundreds of billions of dollars. Marpai is positioned to capture a portion of this market by focusing on self-funded employers and offering AI-powered solutions.
Upturn SWOT Analysis
Strengths
- AI-powered technology
- Focus on preventative care
- Potential for cost savings for employers
- Experienced leadership team
Weaknesses
- Relatively small market share
- Limited brand recognition
- Reliance on technological capabilities
- Dependence on successful AI implementation
Opportunities
- Growing demand for cost-effective healthcare solutions
- Increasing adoption of self-funded health plans
- Partnerships with healthcare providers and technology companies
- Expansion into new markets
Threats
- Competition from larger, established players
- Regulatory changes in the healthcare industry
- Data security and privacy concerns
- Technological obsolescence
Competitors and Market Share
Key Competitors
- UNH
- CI
- WCG
- HQY
Competitive Landscape
Marpai faces intense competition from larger, more established players with greater resources and brand recognition. Its AI-driven approach is a potential differentiator, but its success depends on demonstrating tangible cost savings and improved health outcomes.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is subject to company specific performance.
Future Projections: Future growth projections are dependent on the financial performance of the company.
Recent Initiatives: Recent initiatives should be researched in the company's financial reports.
Summary
Marpai Inc. is a company attempting to leverage AI in the healthcare space. While its AI-powered approach presents an opportunity, it faces significant competition from established players with greater resources. The company's success hinges on demonstrating the tangible benefits of its technology and capturing a larger market share. Regulatory and data security concerns represent ongoing challenges.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Analyst Reports
- Third-party financial databases
Disclaimers:
This analysis is based on available public information and is not financial advice. Market conditions and company performance can change rapidly. Please consult with a financial professional before making any investment decisions. Market share data is based on available information which can be limited and may not reflect precise figures.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Marpai Inc
Exchange NASDAQ | Headquaters Tampa, FL, United States | ||
IPO Launch date 2021-10-27 | CEO & Director Mr. Damien Francis Lamendola | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 117 | Website https://www.marpaihealth.com |
Full time employees 117 | Website https://www.marpaihealth.com | ||
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.